Chronic Tubulointerstitial Nephritis: Histopathologic Findings


TREATMENT


The treatment of CTIN focuses on identifying and addressing correctable risk factors, such as medication use, metabolic abnormalities, and infections. Except in cases of neoplastic and hereditary disease, renal dysfunction is often reversible if the inciting agent is removed early enough. Patients with a significant amount of inflammation on biopsy may be candidates for immunosuppression, although no randomized control trials have supported its use. The two most important risk factors for progression to end-stage renal disease are the serum creatinine concentration at the time of diagnosis and the extent of tubulointerstitial scarring at the time of biopsy.


< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 4, 2016 | Posted by in UROLOGY | Comments Off on Chronic Tubulointerstitial Nephritis: Histopathologic Findings

Full access? Get Clinical Tree

Get Clinical Tree app for offline access